Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oraderm is a specialized pharmaceutical company based in South Africa, operating as a division of Adcock Ingram. The company focuses on the dermatology market, providing a wide range of prescription and over-the-counter treatments for skin conditions such as acne, eczema, psoriasis, and fungal infections. Oraderm's portfolio includes well-known brands like Efudix for skin cancer and various topical corticosteroids and antifungals. They serve as a key player in the Southern African healthcare landscape, offering both locally manufactured and licensed international dermatological products. The company maintains strategic partnerships with global pharmaceutical firms to bring innovative skin care solutions to the local market. As part of the Adcock Ingram group, Oraderm leverages extensive distribution networks and manufacturing capabilities to reach patients across Sub-Saharan Africa.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oraderm.